Ankylosing spondylitis: a case report with review of literature
DOI:
https://doi.org/10.52981/sjms.v11i2.1087Keywords:
Ankylosing spondylitis, Spondyloarthritis, back pain, bamboo spineAbstract
Background: Ankylosing spondylitis is a relatively common worldwide chronic inflammatory disease that usually affects spine, sacroiliac joints in addition to peripheral joints and affects multiple other tissues, which can progress to bony fusion of the spine.
Objective: To fill the gap of the absence of a published description of this condition in Libyan patients and to compare of the clinical presentation and other aspect of the condition in a Libyan patient with what is known worldwide.
Materials and Methods: A case report of a 60 year old Libyan male who has Ankylosing spondylitis and then review the available literature.
Results: The patient has been having a chronic low back pain and stiffness for the last 26 years. His symptoms are most severe in morning and improve with movement. He developed stiffness and limitation of movement of the neck and restriction of movements of the shoulder and hips. Examination showed kyphosis and limited neck movement and decreased chest expansion. His score on Bath Ankylosing Spondylitis Disease Activity Index is 6. His x-rays showed bamboo spine appearance of spine and osteoarthritis in both shoulder joints and hip joints. His presentation fits both European Spondyloarthropathy Study Group diagnostic criteria for spondyloarthropathies and the modified New York Criteria.
Conclusion: Our Libyan patient shows a classical clinical and radiological picture of the condition and the diagnostic criteria and severity index could be applied easily to his cases.
References
2. Slobodin G, Rosner I, Rimar D, Boulman N, Rozenbaum M, Odeh M. Ankylosing spondylitis: field in progress. Isr Med Assoc J. 2012 Dec;14(12):763-7.
3. J Sieper, J Braun, M Rudwaleit, A Boonen, and A Zink. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002 Nov; 61(Suppl 3): iii8–iii18.
4. Yang Z, Zhao W, Liu W, Lv Q, Dong X. Efficacy evaluation of methotrexate in the treatment of ankylosing spondylitis using meta-analysis. Int J ClinPharmacolTher. 2014 May;52(5):346-51.
5. Zhang Z, Dai D, Yu K et al. Association of HLA-B27 and ERAP1 with ankylosing spondylitis susceptibility in Beijing Han Chinese.Tissue Antigens. 2014 May;83(5):324-9.
6. Qi J1, Li Q, Lin Z et al. Higher risk of uveitis and dactylitis and older age of onset among ankylosing spondylitis patients with HLA-B*2705 than patients with HLA-B*2704 in the Chinese population.Tissue Antigens. 2013 Dec;82(6):380-6.
7. Kim TH, Uhm WS, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. CurrOpinRheumatol. 2005 Jul;17(4):400-5.
8. Xu HY, Wang ZY, Chen JF et al. Association between Ankylosing Spondylitis and the miR-146a and miR-499 Polymorphisms.PLoS One. 2015; 10(4): e0122055.
9. Woodward LJ, KamPC.Ankylosing spondylitis: recent developments and anaestheticimplications.Anaesthesia. 2009 May;64(5):540-8.
10. Dougados M, van der Linden S, Juhlin R, et al. The European Spondyloarthrophay Study Group.Criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991;34:1218-1227.
11. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011 Dec;22(6):554-60.
12. Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthop. 2011 Dec 18; 2(12): 107–115.
13. Horst-Bruinsma IE van der: Clinical aspects of ankylosing spondylitis. In Ankylosing Spondylitis. Diagnosis and Management Edited by: van Royen BJ, Dijkmans BAC. New York, London: Taylor and Francis;2006:45-70.